{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:08:27Z","timestamp":1788836907668,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000028","name":"Institute of Circulatory and Respiratory Health","doi-asserted-by":"publisher","award":["PJT-173313"],"award-info":[{"award-number":["PJT-173313"]}],"id":[{"id":"10.13039\/501100000028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013062","name":"G\u00e9nome Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021219","name":"Partenariat Canadien Contre Le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cjca.2026.04.034","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:05:58Z","timestamp":1778108758000},"page":"2240-2247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epidemiologic Implications of the 2025 Hypertension Canada Guideline on Hypertension Prevalence, Treatment, and Control: A Population-based Cohort Study"],"prefix":"10.1016","volume":"42","author":[{"given":"Victoria","family":"Ivensky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Hundemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross T.","family":"Tsuyuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0098-3735","authenticated-orcid":false,"given":"R\u00e9mi","family":"Goupil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2026.04.034_bib1","doi-asserted-by":"crossref","first-page":"E549","DOI":"10.1503\/cmaj.241770","article-title":"Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care","volume":"197","author":"Goupil","year":"2025","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2026.04.034_bib2","first-page":"596","article-title":"Hypertension Canada\u2019s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children","volume":"36","author":"Rabi","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2026.04.034_bib3","first-page":"732","article-title":"Worsening hypertension awareness, treatment, and control rates in Canadian women between 2007 and 2017","volume":"36","author":"Leung","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2026.04.034_bib4","doi-asserted-by":"crossref","first-page":"E854","DOI":"10.1503\/cmaj.210140","article-title":"Refocusing on hypertension control in Canada","volume":"193","author":"Leung","year":"2021","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2026.04.034_bib5","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.cjco.2024.05.012","article-title":"Prevalence, patient awareness, treatment, and control of hypertension in Canadian adults with common comorbidities","volume":"6","author":"Leung","year":"2024","journal-title":"CJC Open"},{"key":"10.1016\/j.cjca.2026.04.034_bib6","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Group","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2026.04.034_bib7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","article-title":"Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2026.04.034_bib8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2026.04.034_bib9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(24)01028-6","article-title":"Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial","volume":"404","author":"Liu","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2026.04.034_bib10","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1161\/HYPERTENSIONAHA.124.23597","article-title":"Optimal antihypertensive systolic blood pressure: a systematic review and meta-analysis","volume":"81","author":"Whelton","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2026.04.034_bib11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/HYPERTENSIONAHA.124.23508","article-title":"Treatment in the first month after hypertension diagnosis improves blood pressure control","volume":"82","author":"Barrett","year":"2025","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2026.04.034_bib12","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJMoa2412006","article-title":"Intensive blood-pressure control in patients with type 2 diabetes","volume":"392","author":"Bi","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2026.04.034_bib13","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/ije\/dys160","article-title":"Cohort profile of the CARTaGENE study: Quebec\u2019s population-based biobank for public health and personalized genomics","volume":"42","author":"Awadalla","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.cjca.2026.04.034_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/HYPERTENSIONAHA.120.16163","article-title":"Prediction of cardiovascular events by type I central systolic blood pressure: a prospective study","volume":"77","author":"Lamarche","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2026.04.034_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026603","article-title":"Prediction of cardiovascular events by pulse waveform parameters: analysis of CARTaGENE","volume":"11","author":"Desbiens","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2026.04.034_bib16","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/ndt\/gfw059","article-title":"Central blood pressures in early chronic kidney disease: an analysis of CARTaGENE","volume":"32","author":"Goupil","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjca.2026.04.034_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2377","article-title":"Association of glomerular hyperfiltration and cardiovascular risk in middle-aged healthy individuals","volume":"3","author":"Dupuis","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjca.2026.04.034_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cjca.2026.04.034_bib19","first-page":"14","article-title":"Diabetes Canada 2018 clinical practice guidelines: key messages for family physicians caring for patients living with type 2 diabetes","volume":"65","author":"Ivers","year":"2019","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.cjca.2026.04.034_bib20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2026.04.034_bib21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.04.034_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jash.2018.06.010","volume":"12","author":"Whelton","year":"2018","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.cjca.2026.04.034_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.0406","article-title":"Prevalence of Hypertension, Treatment, and Blood Pressure Targets in Canada Associated With the 2017 American College of Cardiology and American Heart Association Blood Pressure Guidelines","volume":"2","author":"Garies","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjca.2026.04.034_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2017.10.073","article-title":"Potential U.S. Population Impact of the 2017 ACC\/AHA High Blood Pressure Guideline","volume":"71","author":"Muntner","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2026.04.034_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.118.035640","article-title":"Potential cardiovascular disease events prevented with adoption of the 2017 American College of Cardiology\/American Heart Association blood pressure guideline","volume":"139","author":"Bress","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.04.034_bib27","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2026.04.034_bib28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11906-013-0403-y","article-title":"Association between pre-hypertension and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies","volume":"15","author":"Guo","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.cjca.2026.04.034_bib29","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2026.04.034_bib30","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1097\/HJH.0000000000001547","article-title":"Effects of blood-pressure-lowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure: overview and meta-analyses of randomized trials","volume":"35","author":"Thomopoulos","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjca.2026.04.034_bib31","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.04.034_bib32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jama.2022.7408","volume":"328","author":"Patnode","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2026.04.034_bib33","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/jamainternmed.2020.5028","article-title":"Concordance between blood pressure in the systolic blood pressure intervention trial and in routine clinical practice","volume":"180","author":"Drawz","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cjca.2026.04.034_bib34","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X26003922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X26003922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:32:18Z","timestamp":1788834738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X26003922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0828282X26003922"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2026.04.034","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiologic Implications of the 2025 Hypertension Canada Guideline on Hypertension Prevalence, Treatment, and Control: A Population-based Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2026.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}